Skip to main content
Clinical Trials/ITMCTR1900002527
ITMCTR1900002527Recruiting未知

A multicenter, randomized controlled clinical trial of Bi-Sai-Tong solution for moderate to severe allergic rhinitis

Guangdong Provincial Hospital of Chinese Medicine0 sitesStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
未知
Status
Recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional study

Eligibility Criteria

Ages
18 to 65 (—)
Sex
All

Inclusion Criteria

  • 1. Aged 18 to 65 years, both men and women;
  • 2. Accorded with allergic rhinitis diagnostic criteria;
  • 3. moderate-severe allergic rhinitis;
  • 4. RQLQ scores >= 42 points
  • 5. Patients signed informed consent.

Exclusion Criteria

  • 1. Patients with moderate-severe deviation of nasal septum, sinusitis, rhinopolyp, nasopharynx cancer and other severe nasal diseases;
  • 2. Patients with serious heart,liver,lung,kidney and blood system diseases;
  • 3. Patients with unstable asthma control;
  • 4. Psychiatric patients;
  • 5. Those who are in on-going trial or ready to attend other clinical trials;
  • 6. Allergic to the traditional Chinese medicine ingredients contained in the treatment drug;
  • 7. Women during pregnant stage and breast-feed stage.

Investigators

Sponsor
Guangdong Provincial Hospital of Chinese Medicine

Similar Trials

Effectiveness of Bi-Sai-Tong solution for... | Clinical Trial